Olmesartan Medoxomil Tablet, Coated
Product Images NDC 49252-066

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 49252-066). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Inventia Healthcare Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 01)

Image (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 01)
Chemical structure of olmesartan medoxomil, the active ingredient in OLMESARTAN MEDOXOMIL tablets, is shown in a detailed molecular diagram highlighting the compound's atomic and bond arrangement.*
FDA Label Image

Image (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 02)

Image (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 02)
A line graph depicting the reduction in blood pressure (mmHg) with increasing doses of Olmesartan Medoxomil tablets (mg). The graph shows two lines representing systolic and diastolic blood pressure reductions, with systolic BP reduction consistently higher across doses up to 80 mg.*
FDA Label Image

9474a8a6-a81f-42ea-8bee-9bc0f9e87a03 (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 03)

9474a8a6-a81f-42ea-8bee-9bc0f9e87a03 (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 03)
Label for Olmesartan Medoxomil Tablets, USP 5 mg in a coated tablet form. The label indicates a package size of 30 tablets and designates the product for prescription use only (Rx only). Manufactured by Inventia Healthcare Limited, India. The label includes storage instructions and a barcode.*
FDA Label Image

9474a8a6-a81f-42ea-8bee-9bc0f9e87a03 (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 04)

9474a8a6-a81f-42ea-8bee-9bc0f9e87a03 (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 04)
Packaging label for Olmesartan Medoxomil Tablets, USP 20 mg, coated oral tablets. The box contains 100 unit-dose tablets (10x10). Labeler is Inventia Healthcare Limited, India. The label includes NDC number 49252-066-57 and storage instructions at 20-25°C. Product details and barcode are shown on the packaging.*
FDA Label Image

9474a8a6-a81f-42ea-8bee-9bc0f9e87a03 (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 05)

9474a8a6-a81f-42ea-8bee-9bc0f9e87a03 (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 05)
Label for Olmesartan Medoxomil Tablets, USP, 20 mg oral coated tablets. The label states the quantity of 30 tablets, with active ingredient olmesartan medoxomil USP 20 mg per tablet. The product is manufactured by Inventia Healthcare Limited, India. The label includes storage instructions and a barcode.*
FDA Label Image

9474a8a6-a81f-42ea-8bee-9bc0f9e87a03 (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 06)

9474a8a6-a81f-42ea-8bee-9bc0f9e87a03 (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 06)
Packaging label for Olmesartan Medoxomil Tablets, USP 40 mg, coated oral tablets in unit-dose packaging. The label indicates a quantity of 100 tablets (10x10) with the NDC 49252-067-57. Manufactured by Inventia Healthcare Limited, India. The label includes dosing instructions to refer to the package insert and storage recommendations.*
FDA Label Image

9474a8a6-a81f-42ea-8bee-9bc0f9e87a03 (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 07)

9474a8a6-a81f-42ea-8bee-9bc0f9e87a03 (9474a8a6 A81f 42ea 8bee 9bc0f9e87a03 07)
The label for Olmesartan Medoxomil Tablets, USP 40 mg by Inventia Healthcare Limited. It is an oral coated tablet in a package of 30 tablets. The label includes dosage storage instructions, manufacturer details from India, and a barcode. The NDC is 49252-067-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.